Additional Information

Description

Injectafer 750 mg/15 mL vial is an intravenous iron replacement therapy indicated for the treatment of iron deficiency anemia in adult and pediatric patients who cannot tolerate or have an inadequate response to oral iron supplements. The formulation contains ferric carboxymaltose, a stable iron complex that allows for controlled iron release and efficient absorption.

This parenteral iron therapy is administered as an intravenous injection or infusion, ensuring direct iron delivery into the bloodstream. The controlled release mechanism helps maintain stable serum iron levels, reducing the risk of oxidative stress and iron overload. The formulation is free from dextran, reducing the likelihood of hypersensitivity reactions.

Injectafer is typically administered in one or two doses, depending on the severity of iron deficiency and the patient’s body weight. Each 15 mL vial contains 750 mg of iron, allowing for a high-dose treatment approach with fewer administrations. The dosing regimen enhances treatment adherence and reduces the need for frequent hospital visits.